| Subject: | FDA MedWatch – Nationwide Recall of Two Lots of Accusure Insulin Syringes |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 24 Aug 2009 - 04:00 pm |
| Qualitest Pharmaceuticals, Inc., has issued a voluntary nationwide recall of Accusure® Insulin Syringes (1/2 cc - 31 G - Short Needle) with lot number 6JCB1 (Expiration 10/2011) - NDC 0603-7001-21. This lot was distributed between January 2007 and June 2007 to wholesalers and retail pharmacies nationwide (including Puerto Rico). Qualitest has also issued a voluntary nationwide recall of Accusure® Insulin Syringes (1 cc - 31 G -Short Needle) with lot number 7CPT1... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|